Investors

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Parnell Pharmaceuticals Holdings’s financial performance into perspective.

 

Press Releases

Events & Presentations

Jan 11, 2018
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Nine Months Ended September 30, 2017; Board and Senior Management Changes; Strategic Review of Development Pipeline Including Zydax Canine and 2018 Guidance

Jan 11, 2018
Notice of General Meeting and Explanatory Memorandum

Jan 4, 2018
Parnell Appoints Tony G Hartnell AM to Board of Directors

May 30, 2017 at 4:00 PM CT
Parnell Pharmaceuticals Holdings Ltd Annual General Meeting

May 24, 2017 at 5:00 PM ET
Parnell Pharmaceuticals Holding Ltd Business Update
Investors and analysts may access the conference call by dialing (877) 244-6184 (U.S./Canada) or (920) 663-6271 (International) and using the conference ID# 27440696

View all press releases >>

View all events & presentations >>

 
To
Top